Spring direct naar de hoofdnavigatie of de inhoud
‘The best results are obtained when there is an exchange of creative thinking between the patent attorney and the client. I truly enjoy achieving and maintaining such synergy.’
Annemiek Tepper

Annemiek Tepper

  • Chemistry
  • Life Sciences
  • European and Dutch Patent Attorney
  • Partner

Annemiek Tepper joined V.O. in 2002. During her academic career, she spent one year at the University of Chapel Hill (USA) and at the Pasteur Institute in Paris. Annemiek studied biochemistry at the University of Groningen. She obtained her PhD at the Netherlands Cancer Institute (Amsterdam).

Continue reading

Her specialties include biochemistry, biotechnology, oncology, immunology, diagnostics, medical technology, dairy science and food technology. She is actively involved in assessing the patentability of new developments, and in drafting and prosecuting patent applications worldwide. Other activities include evaluating third party patent portfolios and providing opinions of validity/invalidity and infringement/non infringement. She is also experienced in representing clients in opposition and appeal cases before the EPO. Her clients are diverse and range from academic institutions, SME’s to multinationals.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Post-Doc, Academic Medical Center (2000-2002)

Education

  • PhD, Faculty of Science, University of Amsterdam (2000, with honours)
  • MSc in Biochemistry, University of Groningen (1994, with honours)

Directories

  • Highlighted as ‘exceptional attorney’ by IP Stars Handbook MIP, 2016.

Publications

  • Tepper AD, Ruurs P, Borst J, van Blitterswijk WJ (2001) Biochim. Biophys. Res. Commun. 280:634
  • Tepper AD, Diks SH, van Blitterswijk WJ, Borst J (2000) J. Biol. Chem. 275:34810
  • Tepper AD, Ruurs P, Wiedmer T, Sims PJ, Borst J, van Blitterswijk WJ (2000) J. Cell Biol. 150:155
  • Tepper AD and van Blitterswijk WJ (2000) Methods Enzymol. 312:16
  • Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1999) J. Clin. Invest. 103:971
  • Tepper AD, Boesen-de Cock JG, de Vries E, Borst J, van Blitterswijk WJ (1999) J. Biol. Chem. 272:24308
  • Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1999) J.Biol. Chem. 274:14255
  • Borst P, van Blitterswijk WJ, Borst J, Tepper AD, Schinkel AH (1998) Drug Resistance Update 1:337
  • Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1998) J. Biol. Chem. 273:7560
  • Tepper AD, Dammann H, Bominaar AA, Véron M (1994) J. Biol. Chem. 269:32175
  • Véron M, Tepper A, Hildebrandt M, Lascu I, Lacombe ML, Janin J, Moréra S, Cherfils J, Dumas C, Chiadmi M (1994) Adv. Exp. Med. Biol. 370:607
  • Bominaar AA, Tepper AD, Véron M (1994) FEBS Lett. 353(1):5

Professional & Community Activities

  • Member of the Committee ‘professional orientation’ of the Dutch Patent Association (Orde van Octrooigemachtigden) aimed to promote the profession of patent attorney
  • EPI Tutor

Languages

  • English
  • Dutch

Also see these experts

Frits Michiels

Frits Michiels

  • European and Dutch Patent Attorney
  • Valuation specialist
  • Partner
Peter de Lange

Peter de Lange

  • European and Dutch Patent Attorney
  • Senior Associate
More experts

News

The Legal Quick Scan – your documents in order

Within your organization, various legal documents circulate daily – from employment contract to license and NDA. But is your company’s intellectual property contractually well regulated in these documents­? With the Legal Quick Scan we can assess this for you quickly and at a fixed rate.Continue reading

Your European patent: file an opt-out or not?

When the unitary patent and the Unified Patent Court (UPC) come into force on June 1 this year, all European patents can be involved in enforcement proceedings before this new European Patent Court. This court will then decide enforcement measures and invalidity proceedings in all 17 EU countries at once.Continue reading

The unitary patent is to become reality

Today, the German government deposited its instrument of ratification of the Agreement on a Unified Patent Court (UPCA) with the Council of the European Union.Continue reading

Events

Knowledge for Growth 2023

Flanders Meeting & Convention Center Antwerp, Koningin Astridplein, Antwerpen, Belgium

The crème de la crème of the Belgian life sciences community is present at flanders.bio's annual Knowledge for Growth conference, which brings together decision-makers from the biotech, pharma and medtech, agriculture and chemical industries, as well as investors, universities, top research institutions, policy makers and competence providers.

Continue reading

BIO International Convention 2023

Boston Convention and Exhibition Center, Summer Street, Boston, MA, USA

The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships.

Continue reading